Study of Abarelix in Androgen-Independent Prostate Cancer Progressing After Agonist Therapy
Condition(s):Prostate CancerLast Updated:September 19, 2006Completed
Hide Studies Not Open or Pending
Condition(s):Prostate CancerLast Updated:September 19, 2006Completed
Condition(s):Prostate CancerLast Updated:April 8, 2021Completed
Condition(s):Prostate CancerLast Updated:August 7, 2013Unknown status
Condition(s):Non-metastatic, Hormone naïve Prostate CancerLast Updated:April 18, 2019Completed
Condition(s):Prostate CancerLast Updated:August 21, 2023Recruiting
Condition(s):DevelopmentLast Updated:August 26, 2019Completed
Condition(s):Prostate CancerLast Updated:September 15, 2022Completed
Condition(s):Biochemically Recurrent Prostate Carcinoma; Metastatic Prostate Carcinoma; Oligometastatic Prostate Carcinoma; Stage IV Prostate Cancer AJCC v8; Stage IVA Prostate Cancer AJCC v8; Stage IVB Prostate Cancer AJCC v8Last Updated:January 20, 2021Withdrawn
Condition(s):Cancer Survivor; Obesity; Overweight; Prostate Adenocarcinoma; Stage A Prostate Cancer; Stage B Prostate Cancer; Stage C Prostate Cancer; Stage D Prostate Cancer; Stage I Prostate Cancer; Stage II Prostate Cancer; Stage IIA Prostate Cancer; Stage IIB Prostate Cancer; Stage IIC Prostate Cancer; Stage III Prostate Cancer; Stage IIIA Prostate Cancer; Stage IIIB Prostate Cancer; Stage IIIC Prostate Cancer; Stage IV Prostate Cancer; Stage IVA Prostate Cancer; Stage IVB Prostate CancerLast Updated:April 26, 2023Recruiting
Condition(s):ER+ and AR+ Breast CancerLast Updated:December 9, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.